RAFAEL HOLDINGS, INC. Investing Cash Flow
RAFAEL HOLDINGS, INC. (RFL) reported Investing Cash Flow of -$679.00 thousand for the 9-month period ending 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-04-30 was $6.00K.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-01-31 was -$255.00K, a 100.60% decline year-over-year.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-10-31 was -$430.00K, a 105.01% decline year-over-year.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-07-31 was $163.00K.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities for fiscal 2025 was $44.03M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$10.82M, a 151.01% decline from fiscal 2023.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities for fiscal 2023 was $21.21M.
- RAFAEL HOLDINGS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$63.80M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|
| 2026-04-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$249.00K derived: sum of 2 quarters · filed 2026-06-11 | -$679.00K 10-Q · filed 2026-06-11 | -$516.00K derived: sum of 4 quarters · filed 2026-06-11 | |
| 2026-01-31 | -$255.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$685.00K 10-Q · filed 2026-03-16 | -$522.00K derived: sum of 3 quarters · filed 2026-03-16 | -$7.73M derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-10-31 | -$430.00K 10-Q · filed 2025-12-12 | -$267.00K derived: sum of 2 quarters · filed 2025-12-12 | -$7.47M derived: sum of 3 quarters · filed 2026-06-11 | $35.03M derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-07-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$7.04M derived: sum of 2 quarters · filed 2026-06-11 | $35.46M derived: sum of 3 quarters · filed 2026-06-11 | $44.03M 10-K · filed 2025-10-29 | |
| 2025-04-30 | -$7.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | $35.30M derived: sum of 2 quarters · filed 2026-06-11 | $43.87M 10-Q · filed 2026-06-11 | $42.00M derived: sum of 4 quarters · filed 2026-06-11 | |
| 2025-01-31 | $42.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | $51.08M 10-Q · filed 2026-03-16 | $49.20M derived: sum of 3 quarters · filed 2026-03-16 | $49.83M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-10-31 | $8.57M 10-Q · filed 2025-12-12 | $6.70M derived: sum of 2 quarters · filed 2025-12-12 | $7.33M derived: sum of 3 quarters · filed 2025-12-12 | $4.54M derived: sum of 4 quarters · filed 2025-12-12 | |
| 2024-07-31 | -$1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$1.24M derived: sum of 2 quarters · filed 2025-10-29 | -$4.03M derived: sum of 3 quarters · filed 2025-10-29 | -$10.82M 10-K · filed 2025-10-29 | |
| 2024-04-30 | $631.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | -$2.16M derived: sum of 2 quarters · filed 2025-06-11 | -$8.95M 10-Q · filed 2025-06-11 | -$1.54M derived: sum of 4 quarters · filed 2025-06-11 | |
| 2024-01-31 | -$2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | -$9.58M 10-Q · filed 2025-03-14 | -$2.17M derived: sum of 3 quarters · filed 2025-03-14 | $5.22M derived: sum of 4 quarters · filed 2025-03-14 | |
| 2023-10-31 | -$6.79M 10-Q · filed 2024-12-11 | $621.00K derived: sum of 2 quarters · filed 2024-12-20 | $8.01M derived: sum of 3 quarters · filed 2024-12-20 | $451.00K derived: sum of 4 quarters · filed 2024-12-20 | |
| 2023-07-31 | $7.41M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $14.79M derived: sum of 2 quarters · filed 2024-12-20 | $7.24M derived: sum of 3 quarters · filed 2024-12-20 | $21.21M 10-K/A · filed 2024-12-20 | |
| 2023-04-30 | $7.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-06-14 | -$170.00K derived: sum of 2 quarters · filed 2024-06-14 | $13.80M 10-Q · filed 2024-06-14 | $7.43M derived: sum of 4 quarters · filed 2024-06-14 | |
| 2023-01-31 | -$7.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-03-14 | $6.42M 10-Q · filed 2024-03-14 | $40.00K derived: sum of 3 quarters · filed 2024-03-14 | -$30.44M derived: sum of 4 quarters · filed 2024-03-14 | |
| 2022-10-31 | $13.97M 10-Q · filed 2023-12-14 | $13.94M 10-Q · filed 2022-12-13 | $7.60M derived: sum of 2 quarters · filed 2023-12-14 | -$22.89M derived: sum of 3 quarters · filed 2023-12-14 | -$22.92M derived: sum of 4 quarters · filed 2023-12-14 |
| 2022-07-31 | -$6.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | -$36.86M derived: sum of 2 quarters · filed 2023-10-30 | -$36.89M derived: sum of 3 quarters · filed 2023-10-30 | -$63.80M 10-K · filed 2023-10-30 | |
| 2022-04-30 | -$30.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | -$30.52M derived: sum of 2 quarters · filed 2023-06-13 | -$57.42M 10-Q · filed 2023-06-13 | -$56.89M derived: sum of 4 quarters · filed 2023-06-13 | |
| 2022-01-31 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | -$26.94M 10-Q · filed 2023-03-14 | -$26.41M derived: sum of 3 quarters · filed 2023-03-14 | -$26.69M derived: sum of 4 quarters · filed 2023-03-14 | |
| 2021-10-31 | -$26.90M 10-Q · filed 2022-12-13 | -$26.37M derived: sum of 2 quarters · filed 2022-12-13 | -$26.66M derived: sum of 3 quarters · filed 2022-12-13 | -$38.71M derived: sum of 4 quarters · filed 2022-12-13 | |
| 2021-07-31 | $531.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $249.00K derived: sum of 2 quarters · filed 2022-10-31 | -$11.81M derived: sum of 3 quarters · filed 2022-10-31 | -$8.17M 10-K · filed 2022-10-31 | |
| 2021-04-30 | -$282.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | -$12.34M derived: sum of 2 quarters · filed 2022-06-14 | -$8.70M 10-Q · filed 2022-06-14 | -$9.24M derived: sum of 4 quarters · filed 2022-06-14 | |
| 2021-01-31 | -$12.06M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | -$8.42M 10-Q · filed 2022-03-17 | -$8.96M derived: sum of 3 quarters · filed 2022-03-17 | -$9.00M derived: sum of 4 quarters · filed 2022-03-17 | |
| 2020-10-31 | $3.64M 10-Q/A · filed 2022-02-28 | $3.10M derived: sum of 2 quarters · filed 2022-02-28 | $3.06M derived: sum of 3 quarters · filed 2022-02-28 | $2.92M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-07-31 | -$543.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | -$578.00K derived: sum of 2 quarters · filed 2021-10-18 | -$713.00K derived: sum of 3 quarters · filed 2021-10-18 | -$1.03M 10-K · filed 2021-10-18 | |
| 2020-04-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-06-14 | -$170.00K derived: sum of 2 quarters · filed 2021-06-14 | -$491.00K 10-Q · filed 2021-06-14 | -$526.00K derived: sum of 4 quarters · filed 2021-06-14 | |
| 2020-01-31 | -$135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-03-17 | -$456.00K 10-Q · filed 2021-03-17 | -$491.00K derived: sum of 3 quarters · filed 2021-03-17 | -$797.00K derived: sum of 4 quarters · filed 2021-03-17 | |
| 2019-10-31 | -$321.00K 10-Q · filed 2020-12-15 | -$356.00K derived: sum of 2 quarters · filed 2020-12-15 | -$662.00K derived: sum of 3 quarters · filed 2020-12-15 | -$26.40M derived: sum of 4 quarters · filed 2020-12-15 | |
| 2019-07-31 | -$35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | -$341.00K derived: sum of 2 quarters · filed 2020-10-29 | -$26.08M derived: sum of 3 quarters · filed 2020-10-29 | -$31.24M 10-K · filed 2020-10-29 | |
| 2019-04-30 | -$306.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | -$26.04M derived: sum of 2 quarters · filed 2020-06-09 | -$31.20M 10-Q · filed 2020-06-09 | -$26.96M derived: sum of 4 quarters · filed 2020-06-09 | |
| 2019-01-31 | -$25.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-03-05 | -$30.90M 10-Q · filed 2020-03-05 | -$26.65M derived: sum of 3 quarters · filed 2020-03-05 | -$26.06M derived: sum of 4 quarters · filed 2020-03-05 | |
| 2018-10-31 | -$5.16M 10-Q · filed 2019-12-09 | -$914.00K derived: sum of 2 quarters · filed 2019-12-09 | -$322.00K derived: sum of 3 quarters · filed 2019-12-09 | -$827.00K derived: sum of 4 quarters · filed 2019-12-09 | |
| 2018-07-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $4.84M derived: sum of 2 quarters · filed 2019-10-04 | $4.33M derived: sum of 3 quarters · filed 2019-10-04 | $4.11M 10-K · filed 2019-10-04 | |
| 2018-04-30 | $592.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-06-05 | $87.00K derived: sum of 2 quarters · filed 2019-06-05 | -$136.00K 10-Q · filed 2019-06-05 | -$1.47M derived: sum of 4 quarters · filed 2019-06-05 | |
| 2018-01-31 | -$505.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-12 | -$728.00K 10-Q · filed 2019-03-12 | -$2.06M derived: sum of 3 quarters · filed 2019-03-12 | -$2.50M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-10-31 | -$223.00K 10-Q · filed 2018-12-10 | -$1.55M derived: sum of 2 quarters · filed 2018-12-10 | -$2.00M derived: sum of 3 quarters · filed 2018-12-10 | ||
| 2017-07-31 | -$1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | -$1.77M derived: sum of 2 quarters · filed 2018-10-15 | -$11.22M 10-K · filed 2018-10-15 | ||
| 2017-04-30 | -$444.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-06-11 | -$9.89M 10-Q · filed 2018-06-11 | |||
| 2017-01-31 | -$9.45M 10-Q · filed 2018-03-12 | ||||
| 2016-07-31 | -$3.65M 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |